WEST PHARMACEUTICAL SERVICES INC - 8-K Filing

West Pharmaceutical Services raises full-year 2026 net sales and adjusted EPS guidance following Q3 results exceeding expectations. (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $WST

Read the full article at SEC EDGAR

More Regulatory news